Search
for
Sort by
Research 301–330 of 1000+
- Activity of Angiopteris evecta for baldness treatment
- The pathogenesis of alopecia areata
- Adipose-Derived Stem Cells and Their Secretory Factors for Skin Aging and Hair Loss
- Subject Index
- Immunopathogenesis of Primary Cicatricial Alopecia
- Nonscarring Alopecias
- Complex Regional Pain Syndrome Type I : measurements and treatment
- The childbearing years: hair diseases
- National scientific medical meeting 1996 abstracts
- Abstracts from the Symposium on the Pathophysiology of Hair Growth Organized by the Institute of Dermatology at the Royal Society of Medicine, 29 October 1987
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- Chemoprevention of doxorubicin-induced alopecia in mice by dietary administration of l-cystine and vitamin B6
- Dermatological problems of asylum seekers arriving on boats: A case report from Australia and a brief review
- Acne and acneiform eruptions
- Nanotechnology in Cosmetics: An Overview
- Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
- Chronic telogen effluvium in women: role of micronutrients, a case–control study in north of Iran
- Hair loss due to methylphenidate use: A case study
- Berbagai Tindakan Orang Tua dalam Mengatasi Efek Samping Kemoterapi pada Anak Leukemia di RSUD Dr. Moewardi Surakarta
- The cascading pathogenic consequences of <i>Sarcoptes scabiei</i> infection that manifest in host disease
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- Hair Loss as a Late Complication of Multisystem Inflammatory Syndrome in Children
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Commonly encountered symptoms and their management in patients with cirrhosis
- KeraGLO® Hydrolyzed Keratin: A Healthy Aging Supplement, Improved Skin and Hair in a Placebo Controlled Trial
- A Novel, Hand-Held, and Low-Level Light Therapy Device for the Treatment of Acne Vulgaris: A Single-Arm, Prospective Clinical Study
- He Shou Wu (Polygonum multiflorum)-Induced Hepatocellular Hepatitis
- Desnutrición en Anorexia Nervosa: enfoque psicosomático y tratamiento multidisciplinar Malnutrition in anorexia nervosa: psychosomatic approach an multidisciplinary treatment
- Human Hair Pigment: A Mild Isolation Procedure and a Method for Characterization